Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A randomised, double-blinded and placebo-controlled intervention study. The study aim to evaluate the feasibility, safety and pilot-efficacy of faecal microbiota transplantation as a treatment of severe gastrointestinal neuropathy in patients with diabetes mellitus type 1.
Epistemonikos ID: 5d6ead1757852485ef9ef4020957777c21b1a01e
First added on: May 08, 2024